FDA.report

Application 201270

Type
ANDA
Sponsor
LARKEN LABS INC

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001DEXAMETHASONEDEXAMETHASONETABLET;ORAL1.5MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
68047-702DexamethasoneDexamethasone 1.5 mgLarken Laboratories, Inc.ANDACurrent
70362-702DxevoDexamethasone 1.5 mgSkylar Laboratories, LLCANDACurrent
70362-702DxevoDexamethasone 1.5 mgSkylar Laboratories, LLCANDACurrent
70362-707DxevoDexamethasone 1.5 mgSkylar Laboratories, LLCANDACurrent
70569-151DxevodexamethasonePhlight Pharma, LLCANDACurrent
70569-151DxevodexamethasonePhlight Pharma, LLCANDACurrent
71905-400DexablissdexamethasoneLevins Pharmaceuticals, LLCANDACurrent
79043-200ZCORTdexamethasoneScite Pharma, LLCANDACurrent